Terlipressin
Terlipressin is an analogue of vasopressin used as a vasoactive drug in the management of hypotension. It has been found to be effective when norepinephrine does not help.
Indications for use include norepinephrine-resistant septic shock[1] and hepatorenal syndrome.[2] In addition, it is used in bleeding esophageal varices.[3]
Terlipressin is marketed under the brand name Glypressin (Ferring Pharmaceuticals).
See also
References
- ↑ O’Brien A, Clapp L, Singer M (2002). “Terlipressin for norepinephrine-resistant septic shock”. Lancet. 359 (9313): 1209&ndash, 10. PMID 11955542.
- ↑ Uriz J, Ginès P, Cárdenas A, Sort P, Jiménez W, Salmerón J, Bataller R, Mas A, Navasa M, Arroyo V, Rodés J (2000). “Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome”. J Hepatol. 33 (1): 43&ndash, 8. PMID 10905585.
- ↑ Ioannou G, Doust J, Rockey D. “Terlipressin for acute esophageal variceal hemorrhage”. Cochrane Database Syst Rev: CD002147. PMID 12535432.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH